Breaking boundaries: Ticagrelor monotherapy in high-risk patients

Atherosclerotic plaque formation is a leading cause of arterial thrombosis that significantly impacts global health by instigating major adverse cardiovascular events (MACE) like myocardial infarction (MI) and stroke. Platelets are central to this process, leading to the development of antiplatelet...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	International Journal of Cardiology: Heart & Vasculature
المؤلفون الرئيسيون:	Balbir Singh, D. Prabhakar, Jay Shah, Keshava R, Nakul Sinha, Prafulla Kerkar, Prasant Kumar Sahoo, Rajendra Kumar Premchand Jain, Subhash Chandra, Shuvanan Ray, Shital Sarda
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2024-12-01
الموضوعات:	Ticagrelor Monotherapy Dual antiplatelet therapy Percutaneous coronary intervention Antiplatelet therapy Bleeding risk
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2352906724001921